Arcutis Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	415.62	376.07	196.54	59.61	3.69	-
Revenue Growth (YoY)	95.30%	91.34%	229.73%	1517.09%	-	-
Cost of Revenue	37.65	36.7	19.13	4.99	0.75	-
Gross Profit	377.98	339.38	177.41	54.62	2.93	-
Selling, General & Admin	284.63	274.55	229.39	185.15	122.12	60.97
Research & Development	90.14	77.05	76.42	110.58	182.44	145.56
Total Operating Expenses	374.76	351.6	305.81	295.72	304.56	206.53
Operating Income	3.21	-12.23	-128.4	-241.1	-301.63	-206.53
Interest Income	-	8.9	16.13	12.52	-	-
Interest Expense	-13.47	-12.08	-27.17	-29.71	-15.65	-
Other Non-Operating Income (Expense)	4.13	0.44	0.05	-0.73	5.82	0.17
Total Non-Operating Income (Expense)	-9.34	-2.74	-11	-17.93	-9.83	0.17
Pretax Income	-1.39	-14.97	-139.39	-259.03	-311.46	-206.36
Provision for Income Taxes	0.99	1.17	0.65	3.11	-	-
Net Income	-2.38	-16.14	-140.04	-262.14	-311.46	-206.36
Net Income to Common	-2.38	-16.14	-140.04	-262.14	-311.46	-206.36
Shares Outstanding (Basic)	128	127	121	69	55	49
Shares Outstanding (Diluted)	131	127	121	69	55	49
Shares Change (YoY)	5.24%	5.19%	74.53%	25.94%	11.39%	38.51%
EPS (Basic)	-0.02	-0.13	-1.16	-3.78	-5.66	-4.18
EPS (Diluted)	-0.03	-0.13	-1.16	-3.78	-5.66	-4.18
Free Cash Flow	26.92	-6.31	-112.3	-247.49	-258.05	-175.62
Free Cash Flow Per Share	0.21	-0.05	-0.93	-3.57	-4.69	-3.55
Gross Margin	90.94%	90.24%	90.27%	91.63%	79.54%	-
Operating Margin	0.77%	-3.25%	-65.33%	-404.49%	-8183.04%	-
Profit Margin	-0.57%	-4.29%	-71.25%	-439.79%	-8449.76%	-
FCF Margin	6.48%	-1.68%	-57.14%	-415.20%	-7000.76%	-
EBITDA	5.46	-7.56	-126.44	-240.35	-300.69	-206.08
EBITDA Margin	1.31%	-2.01%	-64.33%	-403.23%	-8157.70%	-
EBIT	3.21	-12.23	-128.4	-241.1	-301.63	-206.53
EBIT Margin	0.77%	-3.25%	-65.33%	-404.49%	-8183.04%	-
Effective Tax Rate	-70.81%	-7.82%	-0.46%	-1.20%	0.00%	0.00%

SEC Filings: 10-K · 10-Q